Transitioning of Herceptin Subsidy to the Pharmaceutical Benefits Scheme (PBS)
Page last updated: 1 July 2015
Frequently Asked Questions (FAQs) have been prepared that outline the Transitioning of Herceptin Subsidy to the Pharmaceutical Benefits Scheme (PBS).
Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer
1 May 2016
The treatment algorithm for anti-HER2 therapies for treating metastatic breast cancer has been updated to reflect recent changes to restrictions for lapatinib and transtuzumab emtansine.
